Related Experiment Videos

Tamoxifen for patients with estrogen receptor-negative breast cancer

¹National Cancer Institute, Bethesda, MD 20889-5105, USA. swains@mail.nih.gov

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|September 19, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges.

ESMO open·2025

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2024

IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer.

NPJ breast cancer·2023

Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer.

ESMO open·2022

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.

Breast cancer research and treatment·2019

See all related articles